Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled trial.
暂无分享,去创建一个
Z. Aziz | J. Strausz | M. Guckert | J. Rolski | M. Russo | J. Herrstedt | S. Grunberg | P. Wissel | S. Lane | Oliver Wright